newsfilter
← Latest News
Business Wire·

BNB Plus Corp. (BNBX) Receives Two New Orders for LineaDNA™ from Genetic Medicine Developers

Provides Updated on BNB Token Holdings and Operating Company Performance BNB Plus Corp. (NASDAQ:BNBX) ("BNBX" or the "Company") today announced that its biopharmaceutical subsidiary, LineaRx, Inc.